Table 1.
Characteristics of 215 study participants at ART initiation, Dar es Salaam, Tanzania, 2019
| Characteristic | n (%) | Mean±SD |
| Age (years) | 37.1±11.5 | |
| Age group (years) | ||
| 18–30 | 69 (32.1) | |
| 31–40 | 72 (33.5) | |
| 41–50 | 45 (20.9) | |
| >51 | 29 (13.5) | |
| Sex | ||
| Female | 146 (67.9) | |
| Male | 69 (32.1) | |
| Level of education | ||
| No education | 10 (4.7) | |
| Primary education | 160 (74.4) | |
| Secondary education | 42 (19.5) | |
| Higher education | 3 (1.4) | |
| Employment status | ||
| Not employed | 117 (54.4) | |
| Employed | 98 (45.6) | |
| Marital status | ||
| Ever married | 102 (47.4) | |
| Never married | 113 (52.6) | |
| Body mass index (kg/m2) | 22.9±4.3 | |
| Underweight | 28 (13.0) | |
| Normal weight | 128 (59.5) | |
| Overweight/obese | 59 (27.4) | |
| WHO HIV clinical stages | ||
| Stage I | 133 (61.9) | |
| Stage II | 30 (14.0) | |
| Stage III | 44 (20.5) | |
| Stage IV | 8 (3.7) | |
| CD4 cell counts (cells/mm3) | 401±253 | |
| <200 | 55 (25.6) | |
| 200–350 | 38 (17.7) | |
| 351–500 | 39 (18.1) | |
| >500 | 83 (38.6) | |
| Lymphocyte counts (x109cells/L) | 1.6±1.2 | |
| <1 | 83 (38.6) | |
| 1–4 | 126 (58.6) | |
| >4 | 6 (2.8) | |
| Proteinuria | ||
| No proteinuria | 104 (48.4) | |
| 1+ (30–100 mg/dL) | 80 (37.2) | |
| 2+ (100–300 mg/dL) | 27 (12.6) | |
| 3+ (300–1000 mg/dL) | 4 (1.9) |
ART, antiretroviral treatment; CD4, Cluster of differentiation 4.